What this means
This trial will test a special geriatric check added to usual transplant assessment for older adults. It has not started yet, so we do not know if it will help.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 60 and over
- Where
- Not listed
The science
- Registered title
- Older Kidney Patient Optimisation Pretransplant
- Trial ID
- NCT07419945 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Kidney Disease, Kidney Failure, Frailty, Cognitive Impairment, Multimorbidity, End Stage Kidney Disease (ESRD), Kidney Transplant, Health Inequity
- What is tested
- Kidney transplant-specific comprehensive geriatric assessment
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Ages
- 60 Years to no maximum
- Dates
- First posted Feb 19, 2026 · updated Feb 19, 2026
Registry summary
The goal of this clinical trial is to learn if a kidney transplant-specific comprehensive geriatric assessment (KT-CGA) can improve the way older adults are assessed for kidney transplantation. The main questions it aims to answer are:
Is it feasible and acceptable to deliver a KT-CGA alongside routine transplant assessment in older adults with advanced kidney disease?
What is the effect of KT-CGA on decision-making about transplant listing and on patient-reported outcomes such as quality of life and frailty?
Researchers will compare participants who receive the KT-CGA plus usual care to those who receive usual care alone.
Participants will:
Continue with their usual transplant assessment process
If randomised to the intervention group, also complete the KT-CGA (a structured set of questionnaires, short memory and function tests, and discussions about wellbeing and support needs, taking about 45-60 minutes)
